Accuray (ARAY) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.43% |
| Dec 31, 2025 | -25.93% |
| Sep 30, 2025 | 20.49% |
| Mar 31, 2025 | 26.79% |
| Dec 31, 2024 | -10.80% |
| Sep 30, 2024 | -54.41% |
| Mar 31, 2024 | -113.51% |
| Dec 31, 2023 | -1.71% |
| Sep 30, 2023 | 12.54% |
| Mar 31, 2023 | 15.25% |
| Dec 31, 2022 | -27.48% |
| Sep 30, 2022 | 18.05% |
| Mar 31, 2022 | -62.84% |
| Dec 31, 2021 | 30.84% |
| Sep 30, 2021 | 21.53% |
| Mar 31, 2021 | 28.27% |
| Dec 31, 2020 | 33.04% |
| Sep 30, 2020 | -32.05% |
| Jun 30, 2020 | 25.02% |
| Mar 31, 2020 | -113.66% |
| Dec 31, 2019 | 28.12% |
| Sep 30, 2019 | -38.81% |
| Jun 30, 2019 | 36.28% |
| Mar 31, 2019 | -47.84% |
| Dec 31, 2018 | -22.97% |
| Sep 30, 2018 | -12.54% |
| Jun 30, 2018 | 17.26% |
| Mar 31, 2018 | -16.25% |
| Dec 31, 2017 | 19.18% |
| Sep 30, 2017 | 7.49% |
| Jun 30, 2017 | 26.33% |
| Mar 31, 2017 | -6.76% |
| Dec 31, 2016 | -25.35% |
| Sep 30, 2016 | -23.04% |
| Jun 30, 2016 | 1.53% |
| Mar 31, 2016 | -31.69% |
| Dec 31, 2015 | -8.82% |
| Sep 30, 2015 | 33.04% |